Coronavirus / COVID

To minimalize mouth rinse-associated cytotoxicity, mouth rinse was largely removed from treated viruses by centrifugation prior to infection of cells.

Findings underscore the need to stay on top of emerging mutations through aggressive genomic surveillance.

New World Obesity Foundation report finds higher COVD-19 mortality rates in countries with higher prevalence of obesity.

A 2-dose vaccination regimen did not show protection against mild-to-moderate disease due to the B.1.351 variant.

CT imaging can detect illness in the lungs better than other medical imaging like MRI.

A Phase 2 study evaluating the therapy could begin immediately based on the findings.

The vaccine is currently authorized for use under an EUA in individuals 18 years of age and older.

There are many reasons for COVID-19 vaccine hesitancy, including its side effects. Here is an examination of side effects in those who have been vaccinated.

Adults with mild cases of COVID-19 did not fare better if they were treated with Ivermectin or placebo.

While most methods of sterilization are effective, efficacy can vary depending on the design of particular masks.

Number of cases surge in the pacific island nation of Papua New Guinea.

A bamlanivimab study showed a 72% reduction in the incidence of COVID-19 and an 80% reduction of progression in the virus in residents in assisted living facilities and nursing staff.

Discussing the link between risk of death from SARS-CoV-2 and levels of Omega-3.

Adverse cardiac phenotypes are associated with greater odds of contracting the virus.

The data additionally show a 94% prevention against asymptomatic SARS-CoV-2 infection, at a time when the country's dominant strain was the B.1.1.7 variant.

France announces a relaxation on restrictions involving international travel outside the EU.

This Emergency Use Listing (EUL) of this single-shot vaccine opens up the door to much of the developing world to gain access to it.

Though the product is authorized more than 70 countries, there is currently no reported US trial data, nor application for authorization to the FDA.

Strong immunologic responses to vaccination for SARS-CoV-2 in COVID-19 survivors suggest that first of 2-dose vaccination could suffice.

The investigational candidate has shown to be 55% and 86.3% effective respectively.

The analysis highlights the importance of high-frequency testing as a complement to social distancing, vaccination, and other mitigation strategies.

Managing mental health in adults living with HIV is paramount during the COVID-19 pandemic.

The acquisition of the Johnson & Johnson pharmaceutical company's vaccine would likely be completed in the latter half of this year.

Plasma proteome confirmed the association between cellular and humoral SARS-CoV-2 immunity.

Johns Hopkins data suggest men are being hospitalized more frequently with infection, and are facing more severe outcomes.